1.
Isr Med Assoc J
; 7(4): 248-51, 2005 Apr.
Article
in English
| MEDLINE
| ID: mdl-15847206
ABSTRACT
Colorectal cancer is a leading cause of cancer death in Israel. Our current understanding of the colorectal adenoma-carcinoma sequence has led to the use of screening for timely detection of polyps and cancer. Digital examination of the rectum is a test that can be performed by all doctors. Fecal occult blood testing, flexible sigmoidoscopy and colonoscopy are the standard screening techniques for patients. Computerized tomography colonography is now entering this field. This review discusses the merits and uncertainties of these strategies as related to the risk of colorectal cancer in selected populations.
Subject(s)
Colorectal Neoplasms/diagnosis , Colonography, Computed Tomographic , Colonoscopy , Colorectal Neoplasms/etiology , Family Practice , Humans , Occult Blood , Palpation , Practice Guidelines as Topic , Risk Factors
2.
J Clin Gastroenterol
; 37(3): 270-1, 2003 Sep.
Article
in English
| MEDLINE
| ID: mdl-12960730
3.
Isr Med Assoc J
; 5(3): 164-9, 2003 Mar.
Article
in English
| MEDLINE
| ID: mdl-12725133
Subject(s)
Adjuvants, Immunologic/therapeutic use , Immunosuppressive Agents/therapeutic use , Inflammatory Bowel Diseases/drug therapy , Adjuvants, Immunologic/adverse effects , Azathioprine/adverse effects , Azathioprine/therapeutic use , Clinical Trials as Topic , Contraindications , Cyclosporine/adverse effects , Cyclosporine/therapeutic use , Humans , Immunosuppressive Agents/adverse effects , Inflammatory Bowel Diseases/immunology , Mercaptopurine/adverse effects , Mercaptopurine/therapeutic use , Methotrexate/adverse effects , Methotrexate/therapeutic use , Safety , Tumor Necrosis Factor-alpha/adverse effects , Tumor Necrosis Factor-alpha/therapeutic use
4.
Rev Gastroenterol Mex
; 68 Suppl 3: 53-6, 2003 Nov.
Article
in English
| MEDLINE
| ID: mdl-15146796
5.
Rev Gastroenterol Mex
; 68 Suppl 3: 58-60, 2003 Nov.
Article
in English
| MEDLINE
| ID: mdl-15146798
ABSTRACT
We need to learn a lot more about the pathophysiology of NSAIDs, especially COX-2, which at present are the drugs of choice.
